Trial Details

UNKNOWN
Basic Information
Clinical ID c3544
Identifier NCT01881464
Trial Title Anti TNF α Improves Endothelial Dysfunction in IBD Patients
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Crohn's Disease
Interventions DEVICE: Endopath from Itamar medical - FDA approved device.|DRUG: Anti TNF Alfa.
Participant Information
Sponsor Carmel Medical Center
City Haifa
Country/Region Israel
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2014-05
Primary Completion Date 2014-06
Completion Date 2018-06